Cleared Traditional

K964728 - STA-LIATEST D-DI TEST KIT

K964728 is the FDA 510(k) clearance for STA-LIATEST D-DI TEST KIT by American Bioproducts Co.. It is a Class 2 Hematology device (product code DAP) cleared through the Traditional 510(k) pathway after a 213-day FDA review.

K964728 · American Bioproducts Co. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1997
Decision
213d
Days
Class 2
Risk

K964728 is an FDA 510(k) clearance for the STA-LIATEST D-DI TEST KIT. Classified as Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (product code DAP), Class II - Special Controls.

Submitted by American Bioproducts Co. (Parisppany, US). The FDA issued a Cleared decision on June 26, 1997 after a review of 213 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all American Bioproducts Co. devices

Submission Details

510(k) Number K964728 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 1996
Decision Date June 26, 1997
Days to Decision 213 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 113d · This submission: 213d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 43
Devices cleared under the same product code (DAP) and FDA review panel - the closest regulatory comparables to K964728.
MDA D-DIMER
K974776 · Organon Teknika Corp. · Apr 1998
VIDAS D-DIMER (DD) ASSAY
K973819 · Biomerieux Vitek, Inc. · Mar 1998
IL TEST D-DIMER
K972696 · Instrumentation Laboratory CO · Nov 1997
STA D-DI CALIBRATOR KIT
K964718 · American Bioproducts Co. · May 1997
AURATEK FDP
K943787 · Organon Teknika Corp. · Sep 1994
FIBRINOSTIKA TDP MICROELISA SYSTEM
K915698 · Organon Teknika Corp. · Aug 1992